据报道,2024年10月28日早盘,生物技术公司莫德纳(MRNA)股价出现大涨,最高上涨5.05%,股价报55.77美元/股,成交量113.64万股,换手率0.3%,振幅4.99%。
从交易数据来看,莫德纳上涨幅度较大,成交量和换手率虽然不算很高,但显示了投资者对该股的关注度增加。分析人士认为,投资者对莫德纳的mRNA技术未来前景保持乐观,以及公司近期财报数据向好等因素,是推动股价上涨的重要原因。
莫德纳最新财报显示,公司实现营业收入2.41亿美元,虽然净利润为负,但毛利为8500万美元,反映营收质量较好。机构评级方面,30%的分析师给予买入评级,59%持有评级。可见,机构对公司前景仍较为看好。
值得注意的是,莫德纳所属的生物技术行业10月28日整体表现不俗,涨幅达0.58%。除了莫德纳大涨外,诸如NLS Pharmaceutics、Monte Rosa Therapeutics等个股涨幅也较大,表现活跃。生物技术板块持续受到资金追捧,投资者对新冠疫苗等创新医药产品的未来需求保持向好预期。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.